=Cyclacel Pharmaceuticals (CYCC) prices public offering

• filed Form EFFECT (Notice of Effectiveness) for an S-1, which was described in an S-1MEF filing

Cyclacel Pharma prices underwritten public offering of units for gross proceeds of $13.2 mln :

The offering is comprised of Class A Units, priced at a public offering price of $2.00 per unit, with each unit consisting of one share of common stock and a seven-year warrant to purchase one share of common stock with an exercise price of $2.00 per share, and Class B Units, priced at a public offering price of $1,000 per unit, with each unit comprised of one share of preferred stock, which is convertible into 500 shares of common stock, and warrants to purchase 500 shares of common stock with an exercise price of $2.00 per share.